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HIV-infected prisoners in Malaysia represent a critical target population for secondary HIV risk reduction interventions and
care. We report on the process and outcome of our formative research aimed at systematically selecting and adapting an EBI
designed to reduce secondary HIV risk and improve adherence to antiretroviral therapy among soon-to-be-released HIV-infected
prisoners. Our formative work involved a critical examination of established EBIs and associated published reports complemented
by data elicited through structured interviews and focus groups with key stakeholders, members of the target population, and their
family members. Based on all information, we adapted the Holistic Health Recovery Program targeting people living with HIV
(HHRP+), an EBI, to consist of eight 2-hour sessions that cover a range of specified topics so that participants may individually
apply intervention content as needed to accommodate their particular substance abuse, HIV risk, and antiretroviral adherence
issues. This study provides a complete example of the process of selecting and adapting an EBI—taking into account both empirical
evidence and input from target organization stakeholders and target population members and their families—for use in real world
prison settings where high-risk populations are concentrated.
1. Introduction
HIV-infected drug users who cycle into and out of correc-
tional systems continue to fuel the HIV pandemic and, as
such, they represent a significant vector for HIV transmission
worldwide. Certain parts of the world, such as Malaysia, are
disproportionately impacted by this problem [1]. A rapidly
expanding body of research literature, including that of
our own international team of investigators, indicates that
criminal justice facilities can be ideal settings for identifying
previously undiagnosed cases of HIV [2–6] as well as
initiating treatment for HIV [2, 7–9]. Providing secondary
HIV risk reduction interventions and engaging inmates in
subsequent care, however, is often challenging [10–12] and
insuﬃcient [13–15].
Because reentering the community upon release is often
characterized by a significant decline in all forms of health-
care for HIV-infected prisoners, this transition can represent
a grave threat to individual and public health. A key issue
facing the correctional and community healthcare systems
today is therefore how to best assist inmates to maintain
the low HIV transmission risk status they have been able to
achieve as they transition from the highly structured prison
setting [16].
Evidence-based interventions (EBIs) have been devel-
oped for HIV-infected drug users in prisons [3] as well
as drug users enrolled in community-based drug treatment
settings [17, 18], though none to date have been successfully
tailored to prepare inmates for the extremely high risk
period immediately following release during which newly
released HIV-infected prisoners are becoming reintegrated
into the community. Our research team has addressed this
unmet need by conducting formative research designed
to inform the selection, adaptation, and placement of
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an evidence-based secondary HIV risk reduction and antire-
troviral adherence intervention specifically for implemen-
tation during the transition period when HIV-infected
prisoners are preparing to return to the community. The
complete process and our findings, including the adapted
intervention, are outlined below.
2. Methods
2.1. Formative Research. We prepared for the implementa-
tion of an HIV risk reduction intervention among drug-
involved soon-to-be-released HIV-infected prisoners by
conducting formative research that first involved review-
ing the available evidence-based interventions (EBI; see
http://www.eﬀectiveinterventions.org/), and then selecting
and adapting an EBI, as needed, for implementation among
the target participants in Malaysia. Thus, we sought to
identify an EBI designed for drug-involved HIV-infected
persons that could be readily adapted for use with soon-to-
be-released HIV-infected prisoners in Malaysia.
2.1.1. Selecting an EBI. As in prior studies [19, 20] our first
step was to review all of the EBIs (see http://www.eﬀecti-
veinterventions.org/) that were applicable to the target
population. An EBI was considered applicable to our target
population if was designed for persons characterized as
(1) HIV-infected, (2) having a preincarceration history of
opioid dependence, and (3) seeking drug treatment upon
release from incarceration. Second, we rank-ordered the
selected EBIs based on the extent to which the intervention
(1) included content designed to address sex-risk, drug-
risk, and antiretroviral adherence behavior, (2) was theory-
driven, (3) had been implemented with a range of relevant
ethnicities/populations, and (4) had demonstrated feasibil-
ity to be adapted for implementation in relevant clinical
contexts. Using this two-tiered evaluation approach, we
concluded that the Holistic Health Recovery Program for
HIV-infected persons (HHRP+ [21]) would serve as the
optimal foundation for our intervention approach targeting
drug-involved HIV-infected prisoners in Malaysia.
2.2. Adapting an EBI. Because our ultimate objective was to
implement our intervention in a novel cultural context, it
was critical to take into account a host of factors relating
to language, customs, and social norms in tailoring our
intervention approach to accommodate the target popula-
tion. Thus, we incorporated the framework below for this
purpose.
2.2.1. Global Framework: Accommodation, Incorporation, and
Adaptation. First, in order to develop a culturally responsive
intervention targeting HIV-infected prisoners in Malaysia,
our overarching approach involved drawing upon Wiley’s
framework—which includes accommodation, incorpora-
tion, and adaptation—as the three initial courses of action
for working with the target population [22]. Accommodation
required a keen understanding of the communication styles
and literacy practices among the target participants and to
taking such factors into account in developing the interven-
tion content and delivery style. Because our research team
included several native Malaysians with significant expe-
rience conducting community-based intervention projects
with the target population in Malaysia, we were readily
able to engage in this course of action throughout the
intervention development process. Incorporation required
our team to become acquainted with community practices
customs and to incorporate these directly into the interven-
tion approach. Promoters of this perspective emphasize that
community constituents (such as drug treatment programs,
community-based organizations, correctional settings, and
families)must fully understand target participants and adjust
intervention content and delivery to address their needs. For
the purposes of our study, Adaptation involved approaching
the intervention development process with the philosophy
that, in addition to conveying specific information and skills
to reduce health risks, intervention content should also pro-
mote target participants’ adjustment to prosocial norms of
the communities to which they are preparing to return [22].
2.2.2. Elicitation Research. Next, based on the Assessment-
Decision-Administration-Production-Topical experts-Inte-
gration-Training-Testing (ADAPT-ITT) model of interven-
tion adaptation [23], we sought to collect information from
members of the target population, their family members,
and treatment providers and other stakeholders in the target
organizations (i.e., correctional and community treatment
settings) where the intervention was expected to be imple-
mented (Tables 1 and 2). The objective of conducting
interviews with members of the target population was to
assess their baseline knowledge and attitudes about HIV
transmission and risk reduction strategies in order to prop-
erly adapt our intervention. We also sought to understand
their attitudes aboutmethadonemaintenance therapy as part
of a risk reduction strategy and to gain their input about
what type of risk reduction intervention approach they felt
would be most helpful. Because we were aware of the relative
importance placed upon family relationships in Malaysian
culture, as well as the high degree of involvement that family
members were expected to play in terms of supporting
inmates upon release, we conducted separate interviews with
any family members who were willing to participate.
The objective of the interviews with the treatment
providers was to assess their current practices involving the
target population in terms of HIV risk reduction and to
understand the challenges they currently face in that regard.
We also wanted their input in designing and implementing
an intervention that would have a strong likelihood of accep-
tance and success within their prison settings. The prison
counselors were also interviewed to assess their perception
of their patients’ knowledge of HIV as well as their attitude
towards sex- and drug-related risk reduction. Since the coun-
selors were viewed as the most likely be directly involved in
the delivery of a risk reduction program, we also questioned
them about their ongoing risk-reduction-related eﬀorts and
challenges as well as querying them about what they thought
would be needed to make an intervention work best. Our
objective in interviewing correctional oﬃcers was to assess
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Table 1: Instrument for interviews with target population and family members.
Questions for target
population
(1) When you think about problems or concerns that are important in your life right now, which ones
are most important? What do you worry about the most?
(2) Did you receive HIV information in prison? Was it helpful?
(3) Tell me about the ways HIV can be transmitted
(4) Tell me how HIV can be prevented
(5) Do you think that prisoners are having sex and injecting drugs, and if so, are they safe?
(6) Do you like condoms? What do you like/not like about condoms
(7) Do you share needles or do you clean needles or get new needles?
(8) What has been your experience with methadone?
(9) What type of intervention would work best (individual or group)?
(10) How long should each session last?
(11) Is your family aware of your HIV status?
(12) Is it good to involve your family in an intervention before your release?
(13) What can or cannot be discussed with family present?
Questions for family members
(1) Do you worry a lot about your family member being HIV+? What is it about them being HIV+ that
worries you? Did you learn about it (HIV status) directly from your family member or from someone
else?
(2) Do you have any fears or concerns about HIV being transmitted to anyone in your family just by
living in the same house or having meals together?
(3) Do you take any special precautions when your family member is around to keep HIV from being
transmitted?
(4) Did you or other members of your family go to visit your family member while s/he was in prison?
Did you place any conditions on whether s/he could come to live with you upon release?
(5) What do you think causes someone to use drugs?
(6) What do you tell your family member in order to get him/her to stop using drugs? Has it ever
worked?
(7) How do you think families help or hinder a person from stopping using drugs?
(8) What do you think about methadone or buprenorphine? What are the positive things about it and
what are the negative things?
(9) Do you think that programs for HIV education are helpful? What would be the most helpful?
their perception of the methadone program as well as getting
their input about the design of a risk reduction intervention.
The correctional oﬃcer participants were also able to provide
detailed information about what materials could be brought
into the prisons and other logistics that should be considered
when planning to conduct such an intervention.
(1) Participants. We sought to interview recently released
prisoners (and families) who shared key characteristics
with our target population (e.g., HIV-infection, history of
injection drug use, history of drug-related incarceration). We
conducted semistructured interviews with recently released
drug-involved HIV-infected prisoners in Malaysia (n = 8)
as well as their family members (n = 3). All the recently
released prisoners were males and frequency of incarceration
ranged form 2 to 10 times and length of incarceration ranged
from 2 months to 1 year. Only one of the recently released
prisoners mentioned having a wife. During the same time
frame, we conducted focus groups with prison physicians
(n = 5), prison counselors (n = 8), and prison correctional
oﬃcers (n = 4) from several prison facilities throughout
Malaysia (Table 3). Our objective was to interview treatment
providers in correctional facilities involved in assisting HIV-
infected inmates with their HIV-focused healthcare while
incarcerated.
(2) Procedure. As in prior work [19], we used structured but
open-ended instruments to obtain interview data (Tables 1
and 2). All participants were informed that the objective was
to elicit a range of information that could collectively guide
the development of an HIV-focused risk reduction program
that could be implemented during the transition period
in which inmates were being released to the community.
Thus, some items focused on the relevant characteristics of
the target population while other items focused on ways
to optimize intervention content, delivery, and placement
within a facility.
All interviews and focus group sessions were audio-
tape recorded and transcribed in Bhasa and translated to
English. The English translation was backtranslated to Bhasa
to ensure appropriate translation. Trained Bachelor’s and
Master’s level researchers conducted the interviews and
focus group sessions as well as the content analysis of
the data [24] under the supervision of a licensed clinical
psychologist. For the content analysis, responses to each item
were grouped and summarized by twomaster’s level graduate
assistants and results were compared for any inconsistencies.
The primary themes identified formed the basis of the
selection of an appropriate intervention and the subsequent
adaptation of the intervention to meet the specific needs of
the target population. Based on content analyses performed,
the primary themes were identified and are summarized
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Table 2: Interview instrument for treatment providers.
General questions for all
treatment providers
(1) Do you think your patients have suﬃcient information on HIV?
(2) What types of HIV risk behaviors (sex- and drug-related) do you perceive in these patients?
(3) Why do patients continue to practice risky behaviors?
(4) Have your patients disclosed their status to their families?
(5) How do you feel about the methadone program?
(6) What type of intervention would work best (e.g., individual, group)?
(7) How long should each session last?
(8) What materials can or cannot be brought into the prison for the purpose of the intervention?
Questions for physicians
(1) Do you counsel your patients on HIV risk reduction?
(2) Are you uncomfortable administering methadone?
(3) What are the challenges you have experienced (with methadone)?
(4) What are the side eﬀects of methadone your patients have complained about?
(5) What suggestions do you have improving the continuity of care (e.g., methadone therapy and HIV
medications) after release?
Questions for counselors
(1) Do you think there are information deficits that may lead to risky behavior?
(2) Do you think there may be any motivational obstacles that contribute to this risky behavior?
(3) What negative attitudes toward safer sexual and drug behaviors do patients possess?
(4) What norms do patients have that interfere with safer sexual and drug using behaviors?
(5) Do you think there may be any deficits in behavioral skills that may contribute to any risky
behavior?
(6) What has been the reaction from their families and how can we make it easier to disclose?
(7) What approaches do you use right now that may be helping to increase patients’ HIV preventive
behaviors?
(8) Will you be comfortable discussing sensitive issues like sex and condom use with patients?
(9) What mode of presentation would work best (psychoeducational, power-point, handouts)?
(10) What kinds of support could be provided to help you integrate the intervention?
in the section below. The study protocol was approved by
Yale University’s Human Investigation Committee and the
University of Malaya’s Ethics Committee.
3. Results
3.1. Interviews with Target Population and Family Members
Primary Issues Faced When Released. When asked to describe
the key concerns they had while preparing for release, typical
responses from the prisoners included
“My plan when I got out. . . I didn’t have any
plans. Because that time when I was relapsed,
then I was confirmed that I got TB. When I got
cured from TB, I didn’t plan for anything. I just
planned to quit this drug taking, didn’t want to
use any drugs, didn’t want to become a burden
to my parents. My concern? Relapsing, smoking
heroin” and “one of the reason is that la. . . using
the drug back, Afraid that you will be like before?
Everything will be haywire. My life before. . . in
simple terms. . . I. . . when I was taking drugs. . .
and when I was taking tablets. . . one day I can. . .
spend up to hundreds of ringgit. . . until I am
unconscious. Sometimes for days. I take tablets. . .
I injected.”
When asked how soon they resumed drug use after their
release, responses included
“. . . the same day” and “Not long. . . not even up
to a week.”
Half of the participants reported they had injected heroin
upon release and that it was typical to do so within their first
week of release.
Familymembers all reported that they were aware of their
relative’s HIV-positive status and had heard it directly from
the relative. Primary concerns among family members when
their relative was released are exemplified by these responses:
“. . . I think it was more of a hope that he can
[still] have a very long life, but I know that is
diﬃcult because of his condition”, and “. . . you
know, with society, when you have something like
[HIV], people won’t . . . don’t want you to get
married.”
When asked specifically about their willingness to pro-
vide long-term support to their relative and if they had placed
any conditions (e.g., sobriety) on their continuing to live at
home following release from prison, some of the responses
were
“She [the mother]. . . is never really like. . . set in
stone conditions. But she does advise him. . . like
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Table 3: Demographic characteristics of all interview participants.
Target population
(n = 8)
Family members
(n = 3)
Prison doctors
(n = 5)
Prison counselors
(n = 8)
Prison correctional
oﬃcers (n = 4)
Gender Male (8) Male (1) Male (5) Male (6) Male (4)
Age 28–48 Not available 44–64 (mean 55.8) Not available 33–45 (mean 39)
Ethnicity Malay (8) Malay (3)
Indian (2)
Burmese (2)
Chinese (1)
Malay (8) Malay (4)
Prison facility Pengkalan Chepa (8) n/a
Kajang (1)
Penang Island (1)
Pokok Sena (1)
Penor (1)
Kluang (1)
Kajang (1)
Kluang (1)
Penor (1)
Penang Island (1)
Pengkalan Chepa (2)
Pokok Sena (1)
Seremban (1)
Pengkalan Chepa (4)
Yrs work
experience
n/a n/a Mean 1.6
Range = 3–15
(mean 7.4)
Range = 4–6
(mean 5.3)
you know, you got to change and all of that. . . she
always takes him in. . . she’s never. . . never said no”
and “No, no, no. . . no restrictions, nothing. . ..”
Knowledge about HIV Transmission. With regard to gains
in HIV-related knowledge while in prison, one participant
reported
“All we know already. . . in prison all they. . .
they give ah. . . what. . . like brochures. . . All
sorts. . .. There is [peer] counseling. . . for the new
inmates. . ..”
and all who responded agreed that they were provided with
helpful information. When asked about the key modes of
HIV transmission, typical responses included
“Injecting needles. . . sharing. . ., Having sex with
a woman” and “There are three groups right? One
who are drug users, one who is like. . . men (and)
women. . . and the other is from a mother to her
child.”
Several participants indicated that they believed HIV could
be transmitted via saliva, shared cooking and eating uten-
sils, and by being too close to children. Further, several
participants were unaware that HIV transmission can occur
through sharing drug cookers although they knew that it
could be transmitted by sharing syringes.
All family members indicated that they knew that HIV
could be transmitted via unprotected sex and sharing
needles. When asked if they feared for the health of other
family members, one response was
“Oh yes. In fact. . . first when we. . . we. . . ah. . . we
found that he got HIV, we are scared to share. . .. In
fact, we asked him to, if he is taking. . . taking his
lunch or dinner, we ask him to. . . to use separate. . .
ask him to eat first. (laughs). We eat. . . we eat
later Ah, let’s hope for the best. I leave it to
God. Because. . . because at first, I am a little bit
scared. . ..”
Two of the three reported that they were scared for the health
of other familymembers after learning of their relative’s HIV-
positive status.
Common HIV Risk Behaviors. In the discussion about com-
mon types of HIV risk behaviors among prisoners, regarding
condom use, one participant reported
“. . .We don’t have the allowance for (condoms) in
prison. . . Can’t do anything about it.”
None of the participants had heard of using bleach to sterilize
needles but one participant reported
“No, because when we are around. . . we are
cooking our drug. . . the pot like that. . . we put our
syringe like that. . . and then we cook in there. . .
the water’s boiled. We take out, put our drugs and
we cook it back.”
All participants responded they knew it was important to not
share needles, though only two participants reported never
sharing needles. One participant reported
“Yes, I have shared but with other HIV people
also. . . with infected persons.”
With regard to sexual behavior, most participants reported
abstaining from sex since their release. Responses included
“No. I only concentrate on my drugs only. . .” and
“Because when I get that thing [heroin], I don’t
have the urge at all. . ..”
Of the participants who reported continuing to have sex and
using condoms, one responded
“I’ve used one, but not sure I’m using it right”
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while another indicated that he did not use condoms
regularly. One of these participants added that, although
condoms were good to use for safety, they greatly diminished
sexual pleasure. The other sexually active participant stated
[through the translator]
“Because they are Muslims, they can’t use con-
doms” and “For the singles, they aren’t supposed
to have sex. . . so they may [just] use drugs and not
be too interested in sex.”
Methadone Maintenance as a Risk Reduction Strategy.
Seven of the eight participants were currently enrolled
in methadone maintenance therapy and one of the eight
was receiving suboxone (another opioid agonist therapy
for treating opioid dependence). When asked about their
experience with methadone, some of the responses were
“Well, my physical [health] is normal. . .. I can
do anything I want. I don’t have to worry
about money. . . or finding drugs. . .. I feel like I
have become a normal person”, “Ah. . . before, it
was really worse. . .. My. . . my drug addiction. . .
[much] worse. . . but I got this methadone, now
is very slow already. And I think I can ah. . .
makework, I can slowly. . .. I can. . . like normal
people. . . Can. . . can. . . can work. . . can work. . .
that’s why I think this methadone also is very. . .
very good for me. I think I can go on” and “Ahh. . .
not very eﬀective. the suboxzone is better.”
When asked how they felt about being on methadone for
the long term, some responses were
“[Methadone] will interrupt our life because we
will need to show up at the clinic every day and
that will make it diﬃcult to stay in treatment” and
“When we start working, it may be an obstacle to
go to the clinic before work.”
However, all participants reported that they had experienced
and accepted the side eﬀects of methadone—primarily
sleepiness, constipation, itching, skin infection, vomiting,
and diarrhea—as well as accepting the reality that they would
likely need to be on methadone long-term as indicated by
“Have to accept that reality—that we need to be
on this for a long time to come.”
Regarding their impression of the role of methadone,
some responses of family members were
“Now he seldom. . . goes out to meet his. . . friends
and all. He stays at home. . . [laughs] . . . and
is very much better. You can see some improve-
ment in him” and “He said in his opinion,
the methadone is really great, good, really helps
[mentions son’s name] . . . you know ahh. . . helps
him a lot. He’s improving a lot. But sometimes he
said he notices that he ah. . . can’t sleep very well.”
Family members all reported being somewhat familiar with
drug treatment therapies including methadone and had a
generally positive impression of the potential role they can
play in recovery. In particular, family members believed
that this type of treatment helped with urges to return to
prior drug-using behaviors. Two family members expressed
interest in learning more about it.
Intervention Content and Delivery. When asked for ideas to
help design an appropriate HIV risk reduction program,
participants expressed that the target population would likely
want to participate in a risk reduction type of intervention as
exemplified by
“Before. . . before. . . 1 month or 2 months. . .
maybe good for. . . maybe eﬀective. . . one month
or 2 months before release. . ..”
When queried specifically about the mode of intervention
delivery, participants tended to favor a group as opposed to a
one-on-one session format.
With regard to learning about condom use, some
responses were
“Yes, it would be useful for those who are married
and have a wife” and “Yes, it would be useful as
well for [an unmarried prisoner].”
It was also suggested that the families of prisoners need to
know more about HIV and how it is and is not transmitted.
When asked about the extent to which it would be helpful
to have their family actually involved in the intervention,
participants were divided as exemplified by the following
responses
“Most people who enter prisons, they are like me—
hardcore. Their families wouldn’t want to come. . .
They are fed up with seeing us in the prisons.
Anyway, it would be hard. They’d have to spend [a
lot of money]” and “I think it would be better. . ..”
Participants also expressed that the usefulness of family
involvement in the intervention content would greatly
depend on the topic. For example when asked specifically if
sexual behavior could be discussed with family around, one
response was
“Maybe for the married ones, with their wives,
but not those who are still single, it wouldn’t be
appropriate.”
Participants felt that it would be helpful to include family
members in content related to methadone therapy and HIV
medication management. All participants reported that their
families were aware of their HIV status and all stated that
they had returned, or were going to return to living with their
family immediately upon release.
When family members were asked to describe the best
way for someone to completely stop using drugs, participants
responses included
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“. . . the most important thing I think is encour-
agement from the family. Don’t just leave, . . . leave
him. . . alone or on his own.”
Family members all reported trying to help their relative by
giving advice and seeking professional help as indicated by
“. . . if he ask questions, if he asks. . . advice, we just
give advice—say this drug is not. . . not good for
you. We start asking questions—what is the best,
ah. . . best method to. . . I mean to ask for help. And
then we. . . the first thing, we saw the Professor. . ..”
and they reported feeling that these types of eﬀorts had been
fruitful. When they were asked if they would find HIV and
methadone maintenance education helpful, their responses
were positive:
“Yes. To be frank, . . . I don’t know anything. . .”
and “I think yes. I want to. . .. I want to knowmore
about. . .. I don’t know. . . I don’t exactly know
what is really the methadone. . . ah. . . what is it
called. Is it a type of medicine? Is it a drug or not?
I’m not very sure. . ..”
However, when queried about whether they would be willing
to go to the prison or treatment center to get some education,
one participant responded
“Ah. . . she said that ah it’s [a good idea] . . . but
you need to ensure that the family wants to do this
since it might be diﬃcult” and another, “I don’t
think so. . ..”
3.2. Interviews with Treatment Providers
3.2.1. Interviews with Prison Physicians (n = 5)
Patients’ Knowledge about HIV and Risk Reduction. When
asked about their patients’ level of knowledge about HIV
transmission, one of the prison physician participants
reported
“Mostly, they know because HIV positive people
already have suﬃcient knowledge about that. For
myself, I used to do every three months from. . .
and I present it. I choose one day for. . . that
day no other prisoner can come into my place. . .
and I talk to them. . .. I go through with them
with their family not with the help of the Prison
Department. . . because of people around, they
very scared because they don’t know that HIV
never goes through from the saliva, . . . they all
wear the mask and they all wear the gloves. . ..”
They all tended to agree that there was an adequate level of
knowledge about HIV. Only one physician reported feeling
that it was necessary to counsel his patients about the various
types of HIV risk. Some reasons for choosing to not counsel
patients in this regard were captured in this comment:
“The problem. . . is the counselor. We have no
communication with the counselors who are uni-
formed staﬀ; we are non-uniformed. So that is a
big big barrier. [When] we approach them, they
think “who are you to tell met. . ..” that sort of
attitude. So there is a big communication gap
with the counselors [and physicians] . . . forget
the prisoners. They come for treatment—yes, I
do see them—but if you think, I do talk to them
counseling wise. . . Socially, I do not have the time,
I do not have the manpower on my, in my clinic. I
don’t have that.”
Common barriers were not having enough time, concern
about confidentiality issues (i.e., they have no right to speak
with prisoners in the absence of prisonmanagement), and an
undesirable working relationship with the prison counselors
who are primarily responsible for speaking with patients.
When asked why they believed their patients continue to
practice risky behaviors such as drug use and sharing needles,
example of the physicians’ response is
“Some of our patients, most of our clients are not
staying with their family members, they move to
stay with their friends. They. . . stay. . . around the
area for the drugs” and “I talk to them and they
give me the points. They smoke.”
Methadone Maintenance as a Risk Reduction Strategy. When
probed for their views about the use of methadone as part of
a risk reduction program, an example of their response is
“[When released from prison], they will definitely
go back to whatever it is [their drug of choice],
but if you can put them [on methadone], the
relapse rate after release will probably be reduced
by 50%.”
Physicians also reported that their patients were quite
enthusiastic about enrolling in methadone maintenance as
exemplified by
“When we started talking to them about
methadone therapy and now I find every one of
them comes to me and. . . give me a note. So I
give a lot of notes to them saying that that if you
are interested in the methadone therapy, go to the
clinic, pharmacy clinic to get the treatment. So I
think a lot.”
Some potential challenges were noted, however, including
the need for good communication across prison staﬀ exem-
plified by this comment:
“No In my opinion giving an administrational
methadone is not a problem, on our part. The
problem I feel the prison, is concerning the pre-
methadone counseling where we are not involved
at all. We don’t know anything.”
Finally, physicians also expressed concerns that there were
too few methadone programs outside the prisons and
that some patients would be faced with the decision to
either travel long distances for treatment or to discontinue
treatment.
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Antiretroviral Therapy following Release. When asked about
prisoners’ ability to continue proper adherence to antiretro-
viral medications following release, some of their responses
were
“[If] you start them on methadone, it is not as
much of a problem because they will definitely
go look for a methadone program where it can
be continued, but if he is on HAART and doesn’t
find family support when released, he is not going
to be able to continue with the HAART. That’s
our worry” and “We. . . oﬃcer, prison doctor. . .
as well as Health Department. Health Depart-
ment is pushing this very much. . . for HAART
treatment. . . because. . . HAART specialist. . . very
very diﬃcult to get an appointment with the
HAART. . .. I can get the appointment. . . HAART
treatment and the follow up, CD4 count and. . . so
to get that. . . that is very hard.”
The general opinion was that HIV management was very
diﬃcult inside and outside the prisons.
Family Involvement. When asked whether family involve-
ment should be encouraged in a risk reduction program,
some of their responses were
“The only people who will accept them in
Malaysia, I tell you, and in my opinion are
the family. They are not welcomed by any other
group” and “. . . but there are prisoners who tell
you that they have nobody to go back to, nobody
wants me and you see, I am going to be released. . .
within the next few weeks, I will be back here. And
the cycle goes on. They are released, and within a
few weeks they are back.”
Concerns about having families visit the prisons were raised
as exemplified by
“This is a very diﬃcult situation. We can do
that but some of them. . . [it is] very diﬃcult to
meet their family member” and “Because of their
busy. . . security system. . . we cannot. . . sometimes
it is very diﬃcult to [do that].”
One suggestion for supporting the prisoners after release was
“Basically, we find prisoners. . . most of our HIV+
prisoners are drug addicts. So we have drug users,
they either don’t have family or nobody wants
them, so they have nowhere to go. Even if you try
to contact their family, the family doesn’t want to
take. . . them home, carry on. so what I am trying
to do now is that, we feel that. . .HIV and HAART
treatment itself like some of our patients have. . .
so we have to find a half way house where they can
go to some place where they will take care of them
and continue with whatever treatment that we
carry on and later if he is able to support himself
then we carry on for. . . years.”
Intervention Content and Delivery. The physician partici-
pants all agreed that conducting group sessions would be
the most feasible option in terms of time constraints. When
further discussing the details of the intervention content, one
physician encouraged the use of videos clips and pictures, as
exemplified by
“Pictures, video, speaking in demonstrations. . .
that’s something that can be very helpful.”
They stressed the need for a multidisciplinary strategy with
everyone making a contribution, as captured by
“I think from the start that everybody should be
told that this is a multidisciplinary approach.”
Physician participants also strongly agreed on several
issues specific to patient care including the need to incor-
porate the concurrent use of methadone and antiretroviral
medication for patients as exemplified by
“. . . they have to go somewhere—otherwise it
is very diﬃcult to start them on the treatment.
Otherwise. . . if you start them on methadone, is
not much of a problem but they will definitely go
look for methadone if you really find a place for
them to go and get it. But if they go to Kajang and
get HAART and then doesn’t find family [after
release], he is not going to go and continue with
the HAART. That’s our worry.”
They emphasized the need for more methadone programs
outside the prisons, and the need for more halfway houses
where patients could go after release as a transition point
until they can become independent.
3.2.2. Interviews with Prison Counselors (n = 8)
Patients’ Knowledge about HIV and Risk Reduction. The
counselor participants indicated that their patients are
provided suﬃcient information about HIV, safe sex, and
injecting practices but believed that they sometimes ignore
the information provided, as exemplified by
“People usually have the information about how
to use a condom, not sharing needles. . . —before
they are released—at least one day before release,
but we do not know what happens after they are
released” and “They know those things. . . we have
told them about HIV. . . about protection, how to
use it [condoms].”
They all agreed that the patients tend to be relatively
well informed while incarcerated. Counselors did report,
however, that they are more concerned about prisoners’ sex-
and drug-risk behavior following release, as indicated by
“[Following release], the prisoners are using con-
doms 20% of the time. . .” and “. . . So, the
majority of them are sharing needles, because they
have to, they. . . [feel like] they really need the
drug. . . and they are still sharing cookers and other
things.”
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Patients’ Attitudes about Risk Reduction Behavior. When
questioned about their patients’ attitudes regarding risk
reduction behavior, some responses were
“When they are to have sex with a sex worker, the
one that buys the condom is the sex worker not
the guy, the client. So they don’t know whether the
brand is good or not” and “All the inmates love
the wife. But sometimes, [they] don’t want to use
a condom because like if you want to use condom,
then you have another person.”
This implies that the counselor participants felt that a key
barrier to engaging in condom use for their patients is that
condom use may imply unfaithfulness to their spouse or
primary partner and this may initially make them reluctant
to use condoms with their primary partners. The counselor
participants also reported that they believed their patients
were also reluctant to use condoms because they felt that sex
would be less pleasurable as exemplified by
“. . . that’s one of the problems, because my inmate
also told me, eerr. . . he didn’t want to use a
condom because its [not satisfying].”
Other responses regarding reluctance to use condoms were
“If the inmate is a drug user who is HIV+, in his
house he uses a condom, but outside he doesn’t”
and “. . . usually they do not have [unprotected]
sex with their steady partner. Maybe he will satisfy
his sexual needs in another manner” and “If it’s
a HIV positive sex worker, she’s not interested.
Who gave me the sickness? Why should I prevent
someone else from getting it?. . . Yes, they don’t
care,”
implying that some patients may be willing to protect their
primary partners by using condoms, but not casual partners,
and others may be harboring feelings of revenge.
Regarding drug-related behavior, some of the counselor
participants’ comments were
“One inmate already came in last week and told
me “who cares about HIV, who cares, who cares?
I can share needles with others. The [only] certain
thing is I need drugs now, now, now” and “Usually
they don’t care, they don’t think. They don’t think
about it [HIV prevention]. They want drug, fun,
high. . . When we see those with HIV, the question
of prevention for them doesn’t exist.”
They all tended to agree that their patients’ priority was
to get high, and that they were less concerned with HIV
transmission risk reduction. One counselor mentioned, for
example, that it was not unusual for a patient to convince his
spouse to go into sex work in order to support his drug habit.
When asked if addiction could be managed by
methadone, on response was
“If the patient is in a methadone program and
he is really successful, then he will engage in the
counseling program for methadone. Indirectly, the
methadone program will make him concerned
about other people.”
They all agreed that methadone would enhance an HIV-risk
reduction program.
Intervention Content and Delivery Style. Two of the coun-
selor participants reported that they routinely demonstrate
to their patients how to properly use condoms. Two other
counselors reported not doing this. When asked about
patients’ skills in practicing safe sex, the counselor comments
included
“Not sure [if patients can properly put on con-
doms]” and “His sex, sexual desire. . . he doesn’t
care. . . because if he is high, he will sleep with
anyone.”
They, however, reported that they had been providing
HIV information to their patients and teaching them risk
reduction skills, as indicated by
“We give the inmates information of course—
every day—at least 4 times in one week, ok. We
give them information. A new inmate, after 2
days, we give information about HIV, about AIDS,
about CD4, then about needle sharing. . . about
protected sex” and “I do tell them that just because
you bought a condom doesn’t mean you know how
to use it properly. You must look at expiration date
and know the proper way to use it.”
Regarding their patients’ ability to disclose their HIV status,
counselor comments included
“They don’t know. . . how to tell [them]” and
“When the inmates are scared to tell their wives
about the infection, HIV, they will tell the coun-
selor to contact their wives”
Counselors tended to agree that their patients typically lack
the skills to negotiate safe sex and the skills to disclose their
HIV status to their families or others.
When asked about the barriers they have encountered,
one counselor participant reported
“In 1997, there was an Act released by the Prison
Department that families must be informed of a
confirmed HIV positive inmate’s status. We have
done this before, we called the family, [and] what
arises here is a conflict. Inmates say that this is
a confidential matter. I contact the family and
ask them to come and meet me with the inmate.
I focus more on [encouraging] the inmate to
[tell the family], but what is happening now is
some NGOs are questioning the confidentiality [in
doing that].”
Aside from confidentiality issues, one female counselor also
mentioned that safety could be a barrier to discussing the
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details of sex-risk behavior because she did not feel safe
discussing this topic with her male patients, as captured by
“Because I’m a female, I am not comfortable when
talking to a man inmate about condoms. . .. Very
dangerous to talk too much with a man [like
that].”
There was also some concern that discussing sex a lot would
give patients the license to practice it.
Overall, counselor participants were divided about
whether intervention delivery would best be done in a one-
on-one versus group format and saw advantages to each.
One counselor indicated that, if one-on-one sessions were
used, there should be gender matching to foster rapport and
comfort between patients and counselors. When questioned
about whowould be themost feasible personnel to ultimately
deliver this type of intervention, counselors all agreed that
they were best positioned and qualified for this duty. Related
to this role, counselors indicated that it would be important
to develop a working manual and stressed the need for
cooperation among all the directors and prison staﬀ as
exemplified by
“For this to be more eﬀective, we should have
a manual. The manual will help the counselors.
Not all of the counselors know about MET and
CBT and other information. Not all [counselors]
know. Manual will help and guide..and encourage
us to be more confident.” and “To me, the most
important thing is for the Directors of Institution
to know about this program. If not, there is no
cooperation, every level of prison staﬀ should
know.”
3.2.3. Interviews with Prison Correctional Oﬃcers (n = 4)
Methadone Maintenance as Part of a Risk Reduction Strategy.
When asked about the potential role of methadone as part of
a risk reduction program, some of the responses were
“For me, the prisoners feel they have been given
a chance [and] that we in the prison have given
[them] a chance to be in a program that before
was only done outside of prison. So, for me, his
heart feels that he is not cast aside because we
could run a program that was outside and is now
in the prison” and “it can reduce dependency. It
also will stop the prisoners from taking drugs. . .
relapse. Since the program started here, from
their behavior, I could see that they’re not too
addicted. And their behavior is better. . . before
they were quite aggressive, but after methadone,
their behavior is softer and less aggressive.”
However, one participant added
“For the inmates who are in the methadone
program, their educational level is quite low.
They don’t quite understand the concept of reha-
bilitation. So the methadone program is really
to take away the cravings but not as part of
recovery/rehabilitation.”
The correctional oﬃcer participants indicated that they
do not maintain contact with released prisoners and there-
fore do not know the success rate of those who participated
in the methadone program while in prison. Responding
to whether there was the need for more information, one
response was
“The inmates need more awareness and education
about methadone, its eﬀects, . . . its benefits. The
COs too needs awareness. Its better if we can get
an outsider to come and give a talk.”
When asked about the primary challenges that they face
in implementing the methadone program, one response was
“The inmates on methadone—for most of them—
they would like to see a diﬀerence in a short time
frame. They don’t quite understand that to gain
or to see a diﬀerence, it requires diﬀerent doses.
Usually we will explain to them repeatedly about
the [dose] and eﬀect.”
There was also some discussion of the issues of side eﬀects
such as sleepiness and constipation.
Intervention Content and Delivery Style. When correctional
oﬃcer participants were queried about the optimal content
and delivery of a risk reduction intervention in the prisons,
there was a tendency to favor a one-on-one session format,
as indicated by
“Giving information in group sometimes, you
know people, there will distraction [from others].
So, when it is one-to-one, the information can be
absorbed better. Understanding of the matter will
be clearer.”
It was suggested that the intervention content should be
simple to understand, frequently reviewed, and should last
no longer than one hour in order to improve attention,
memory, and processing of the content.
Correctional oﬃcers agreed that laptop computers could
be brought into the prison for these sessions as well as
syringes, condoms, and replicas for demonstration purposes.
It was also suggested that relevant information in the form
of handouts and worksheets would be useful. In terms of
meeting space, the correctional oﬃcer participants indicated
that counseling rooms are typically available for one-on-one
sessions as well as a 20-person conference room if a group
format is preferable.
Family Involvement following Release. When questioned
about the extent of family support for the target population,
the correctional oﬃcer participants estimated that about
half of the prisoners had disclosed their HIV status to their
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families. Regarding how to address this, one of the responses
was
“Counseling. . .Counseling on how to inform them
and to encourage them. We can invite family here
and provide an environment where inmates can
start informing them.”
The correctional oﬃcers stated that there tends to be a lot
of variation in the responses that prisoners experience from
their families, as exemplified by
“It’s all about the level of knowledge the families
have about HIV. Families mostly know that it
doesn’t have a cure, it’s deadly—you are going to
die. There is also a lot of pressure from society
on the families. Extended family—they need to
make a judgment—do I support my child or my
husband and have negative impact on society or
I can stay away from my husband, child, etc. and
continue living with my community? The prisoner
is sometimes the [relationship] to be sacrificed”
and “For some families, they can accept it, and
for some they really can’t. . . and you see the
relationship is not as tight as it used to be.”
Participants suggested that this situation may be reduced to
a degree if the family had a better understanding of exactly
howHIV is transmitted because misinformation is often part
of the problem.
4. Intervention Refinement
Considered collectively, the formative research data obtained
from prior prisoners, their families, and from treatment
providers (medical doctors, counselor, and correctional
oﬃcers) suggested that it would be most feasible to adapt the
evidence-based Holistic Health Recovery Program for HIV-
infected drug users (HHRP+ [21]), rather than attempting
to implement it or any other existing EBI in the original
form. We concluded that it was more practical to abridge
the original HHRP+ intervention content to focus explicitly
on HIV risk reduction and antiretroviral adherence, to place
greater emphasis on certain interpersonal risk reduction
skills (e.g., disclosure of HIV status, building healthier
support systems including family, negotiating risk reduction
with partners), and to redesign the delivery approach
so that the intervention could be conducted in either a
group or individual format depending on the needs of the
inmate. Greater emphasis in the content was also placed on
postrelease care (e.g., additional hands-on exercises designed
to encourage participants to work through the specific steps
required to connect with appropriate addiction and HIV
care facilities after release) and support systems needed to
foster such care. Equally important, we sought to preserve
the style and process of the evidence-based HHRP+, while
incorporating only the necessary modifications indicated by
the elicitation data.
In redesigning the intervention, we also considered
an array of issues pertaining to the placement of the
intervention within the context of the correctional system in
Malaysia. This process was largely determined by the logistics
of the target organizations as collectively described by the
range of treatment provider participants. The key factors that
we considered were (1) how the intervention could be made
available to a maximum number of target participants, (2)
how it could be positioned to be perceived by participants
and staﬀ as relevant to prisoners’ overall clinical care, (3)
how it could be the least disruptive to the organization’s
routine, and (4) how it could be placed so that it would be
most likely to be sustained over time, as designed, using the
existing human and physical resources available within the
correctional system in Malaysia. The resulting intervention,
the Holistic Health Recovery Program for Malaysia (HHRP-
M; Table 4) consists of eight 2-hour sessions designed to
cover a range of relevant topics so that each participant
may choose to apply intervention content as needed to
their own HIV risk profile and antiretroviral adherence
challenges. Importantly, the HHRP-M intervention manual
was deliberately designed to be suﬃciently flexible so that
content can be readily delivered in a group or individual
format and so that sessions can be delivered in either
consecutive or weekly meetings based on logistics and time
constraints. It was also designed to encourage participants’
concurrent enrollment in drug treatment and HIV care
as complementary risk reduction and relapse prevention
strategies and in order to enhance the likelihood that inmates
will be able to make a healthier transition back to the
community.
5. Disscusion
This study involves a description of the process and outcome
of formative research that was conducted in preparation to
adapt an evidence-based intervention (EBI) for use with
drug-involved HIV-infected soon-to-be-released prisoners
in Malaysia. The Holistic Health Recovery Program for
Malaysia (HHRP-M) is a behavioral intervention that has
been designed to address the HIV risk behavior and HAART
adherence challenges faced by HIV-infected inmates in the
correctional system in Malaysia as they transition back to the
community.
The results of our study suggest that there is a great need
for sex- and drug- risk harm reduction interventions in these
Malaysian prisons and that current and, soon-to-be-released
prisoners will benefit significantly from such an intervention.
It is evident that there is much room for improvement
in the target populations’ level of information about HIV
and risk reduction, and in their motivation and skills to
practice healthy behaviors and these were the major focus in
designing the HHRP-M. For example, the report of sharing
injecting paraphernalia with other infected individuals shows
a gap in the area of reinfection and superinfection. Also,
the significant decline or complete absence of healthcare in
the after reentering the community can have very severe
implications for HIV-positive individuals suggesting the
need to begin an intervention prior to their release.
Our results also show an almost unanimous positive
disposition towardmethadone maintenance and its potential
role in harm reduction and this was observed in all
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Table 4: Outline of adapted intervention sessions.
Group topic Information, motivation, and skills taught
(1) Health care
participation
Actively participating in your health care, Improving skills for partnering with health care providers;
Building ARV adherence skills; HIV and opportunistic infections.
(2) Reducing drug and
sex-related risk and
negotiating RR with
partners
Harms of injecting drugs & harm reduction techniques (e.g., proper needle cleaning); Reducing
cue-elicited craving, Harms of unsafe sexual practices & Safer sex techniques (e.g., condom
applications); Building skills to communicate about risk reduction with your partner.
(3) Healthy lifestyle choices
Learning coping skills; Stress management skills; Building skills to identify and plan healthy daily
activities; Learning & practicing several relaxation techniques; Building skills to identify and plan
healthy daily activities
(4) Preventing relapse to
risky behavior: Recovery as
a journey
Building a road map for the journey of recovery; Relapse prevention skills; Identify early warning signs;
Understanding and managing seemingly irrelevant decisions (SID).
(5) Overcoming stigma
Understand stigma and consequences; Decreasing the strength of the “addict” self & connecting with
the “core” self; Identifying and strengthening the cognitive, aﬀective, and behavioral attributes of a
healthier, non-drug using lifestyle; Building skills to redefine the self as a non-drug user.
(6) Motivation for change;
overcoming helplessness
Understanding the sources of helplessness and the consequences; Identify empowering situations; Build
skills to assess readiness to change; Increase motivation to pursue a healthy lifestyle.
(7) Moving Beyond Grief
Understanding the stages of grief; Build skills to cope with fears related to HIV; Facing fears and
reclaiming control of life; Identifying and prioritizing that which has personal meaning.
(8) Reaching your goals
Learning about memory and concentration and how to improve; Build skills to set goals, establish
priorities, and initiate action; Building skills to improve nutirition pyramid; Developing medication
adherence skill.
groups of participants. Similar findings have been observed
in other studies [25]. A study in Taiwan [26] showed
that methadone maintenance was associated with reduced
mortality, independent of HIV status, in a cohort of newly
released prisoners who had a history of injection drug use.
The role of methadone maintenance in harm reduction has
also been suggested in several studies [27, 28].
Although several barriers to addressing this intervention
were raised, these are issues that could be tackled in the
adaptation process. Wiley’s global framework [22]—which
includes accommodation, incorporation, and adaptation—
was used as an overarching approach to intervention adap-
tation. Our specific adaptation approach was consistent
with the Assessment-Decision-Administration-Production-
Topical experts-Integration-Training-Testing (ADAPT-ITT)
model [23] in which input from the target population
and treatment providers was systematically elicited and
then incorporated into the refinement of an evidence-
based intervention. Information gleaned from these multiple
sources had a significant impact on the features of the
resulting HHRP-M intervention, including the emphasis of
certain content (e.g., family/social support; planning for
post-release treatment) and the flexibility of intervention
delivery. This information was also critical in terms of
informing intervention refinement such that the interven-
tion was perceived as engaging and relevant by participants
and treatment providers as well as realistic in terms of the
organizational characteristics common in the correctional
facilities in Malaysia. For example, overcoming stigma is a
feature of the intervention that will be very useful in this
setting as evidenced by the reluctance of some patients to
disclose their HIV status, and the reaction of some families to
their relative’s HIV status. Prior research has demonstrated
that proactively addressing such issues reduces the need to
make major adjustments to an intervention in the midst of
implementation [20].
The objective of this study was to obtain qualitative
information that could be useful in designing an optimal
adapted evidence-based intervention approach for use in
correctional settings in Malaysia and this resulted in the
limitations that are inherent in research with a qualitative
design. We believe, however, that our careful selection of
participants, a well-established analytical approach, and
the incorporation of published empirical research, resulted
in well-informed and empirically justified decisions that
were used to drive the adaptation process. Our adapted
intervention, HHRP-M, is currently being deployed in a large
RCT in correctional settings in Malaysia and has yet to be
evaluated in terms of quantitative outcomes. Thus, while
there are strong indications of the feasibility of incorporating
HHRP-M in such settings, it is not yet possible to draw
conclusions regarding the intervention’s eﬃcacy in this or
similar settings.
Despite the noted limitations, this study points to
the potential benefits of systematically adapting culturally
responsive intervention approaches across international con-
texts by taking into consideration a range of overarching
cultural issues as well as the very specific issues unique to
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particular clinical setting(s) such as prisons where high risk
populations may be readily reached. A secondary objective of
reporting our formative research process and outcomes was
to inform similar eﬀorts in the future as a growing number
of EBIs have become widely available to interventionists (see
http://www.eﬀectiveinterventions.org/) yet such interven-
tions are not necessarily in optimal form for implementation
in clinical settings without proper adaptation.
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